BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30021817)

  • 1. Keratoprostheses in silicone oil-filled eyes: long-term outcomes.
    Iyer G; Srinivasan B; Agarwal S; Pattanaik R; Rishi E; Rishi P; Shanmugasundaram S; Natarajan V
    Br J Ophthalmol; 2019 Jun; 103(6):781-788. PubMed ID: 30021817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication.
    Iyer G; Srinivasan B; Gupta J; Rishi P; Sen PR; Bhende P; Gopal L; Padmanabhan P
    Cornea; 2011 Oct; 30(10):1083-7. PubMed ID: 21705878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreoretinal aspects of permanent keratoprosthesis.
    Klufas MA; Yannuzzi NA; D'Amico DJ; Kiss S
    Surv Ophthalmol; 2015; 60(3):216-28. PubMed ID: 25890625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India.
    Iyer G; Srinivasan B; Agarwal S; Ravindran R; Rishi E; Rishi P; Krishnamoorthy S
    Ocul Surf; 2019 Jan; 17(1):50-54. PubMed ID: 30157458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C; Yu F; Aldave AJ
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreoretinal Complications and Outcomes in 92 Eyes Undergoing Surgery for Modified Osteo-Odonto-Keratoprosthesis: A 10-Year Review.
    Rishi P; Rishi E; Agarwal V; Nair S; Iyer G; Srinivasan B; Agarwal S
    Ophthalmology; 2018 Jun; 125(6):832-841. PubMed ID: 29342438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of penetrating keratoplasty and vitreoretinal surgery with Eckardt temporary keratoprosthesis in ocular trauma versus non-trauma patients.
    Bové Álvarez M; Arumí CG; Distéfano L; Güell JL; Gris Ó; Mateo C; Corcóstegui B; García-Arumí J
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2547-2558. PubMed ID: 31363832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of long-term results between osteo-odonto-keratoprosthesis and tibial bone keratoprosthesis.
    Charoenrook V; Michael R; de la Paz MF; Temprano J; Barraquer RI
    Ocul Surf; 2018 Apr; 16(2):259-264. PubMed ID: 29501483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteo-odonto-, Tibial bone and Boston keratoprosthesis in clinically comparable cases of chemical injury and autoimmune disease.
    de la Paz MF; Salvador-Culla B; Charoenrook V; Temprano J; Álvarez de Toledo J; Grabner G; Michael R; Barraquer RI
    Ocul Surf; 2019 Jul; 17(3):476-483. PubMed ID: 30986549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Boston keratoprosthesis: 73 eyes from Germany : An overview of experiences from two centers].
    Schaub F; Neuhann I; Enders P; Bachmann BO; Koller B; Neuhann T; Cursiefen C
    Ophthalmologe; 2018 Sep; 115(9):744-753. PubMed ID: 29043440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term visual acuity, retention and complications observed with the type-I and type-II Boston keratoprostheses in an Irish population.
    Duignan ES; Ní Dhubhghaill S; Malone C; Power W
    Br J Ophthalmol; 2016 Aug; 100(8):1093-7. PubMed ID: 26628625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide-field vitreoretinal surgery in eyes with Boston type 1 keratoprosthesis.
    Utine CA; Kaya M; Kasal K
    Int Ophthalmol; 2022 Mar; 42(3):997-1005. PubMed ID: 34637062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
    Shah KJ; Cheung AY; Holland EJ
    Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of penetrating keratoplasty in bullous silicone oil keratopathy.
    Karel I; Kalvodová B; Kuthan P
    Graefes Arch Clin Exp Ophthalmol; 1998 Apr; 236(4):255-8. PubMed ID: 9561356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.
    Driver TH; Aravena C; Duong HNV; Christenbury JG; Yu F; Basak SK; Aldave AJ
    Cornea; 2018 Nov; 37(11):1400-1407. PubMed ID: 30157053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
    Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
    Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.